nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.051	0.0797	CbGbCtD
Bosentan—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0479	0.0749	CbGbCtD
Bosentan—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0479	0.0749	CbGbCtD
Bosentan—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0434	0.0678	CbGbCtD
Bosentan—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0434	0.0678	CbGbCtD
Bosentan—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0374	0.0585	CbGbCtD
Bosentan—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0363	0.0568	CbGbCtD
Bosentan—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0329	0.0514	CbGbCtD
Bosentan—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0329	0.0514	CbGbCtD
Bosentan—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0315	0.0492	CbGbCtD
Bosentan—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0296	0.0463	CbGbCtD
Bosentan—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0279	0.0436	CbGbCtD
Bosentan—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0279	0.0436	CbGbCtD
Bosentan—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0252	0.0394	CbGbCtD
Bosentan—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0252	0.0394	CbGbCtD
Bosentan—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0218	0.034	CbGbCtD
Bosentan—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0211	0.033	CbGbCtD
Bosentan—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0191	0.0299	CbGbCtD
Bosentan—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0191	0.0299	CbGbCtD
Bosentan—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0183	0.0286	CbGbCtD
Bosentan—EDNRB—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00285	0.0459	CbGpPWpGaD
Bosentan—EDNRB—retina—acquired immunodeficiency syndrome	0.00233	0.13	CbGeAlD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00222	0.0356	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00204	0.0329	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00173	0.0279	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00159	0.0257	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00159	0.0255	CbGpPWpGaD
Bosentan—EDNRB—spinal cord—acquired immunodeficiency syndrome	0.0015	0.084	CbGeAlD
Bosentan—EDNRB—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0015	0.0241	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00149	0.0239	CbGpPWpGaD
Bosentan—EDNRB—vagina—acquired immunodeficiency syndrome	0.00145	0.0808	CbGeAlD
Bosentan—EDNRB—lung—acquired immunodeficiency syndrome	0.00137	0.0765	CbGeAlD
Bosentan—EDNRB—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00134	0.0216	CbGpPWpGaD
Bosentan—ABCB11—digestive system—acquired immunodeficiency syndrome	0.00132	0.0739	CbGeAlD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00121	0.0195	CbGpPWpGaD
Bosentan—EDNRA—vagina—acquired immunodeficiency syndrome	0.00119	0.0668	CbGeAlD
Bosentan—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00116	0.0651	CbGeAlD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00115	0.0185	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00114	0.0184	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00113	0.0182	CbGpPWpGaD
Bosentan—EDNRA—lung—acquired immunodeficiency syndrome	0.00113	0.0632	CbGeAlD
Bosentan—EDNRA—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00107	0.0173	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00106	0.0171	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00103	0.0165	CbGpPWpGaD
Bosentan—EDNRB—brain—acquired immunodeficiency syndrome	0.000967	0.0541	CbGeAlD
Bosentan—EDNRA—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000961	0.0155	CbGpPWpGaD
Bosentan—EDNRB—lymph node—acquired immunodeficiency syndrome	0.000935	0.0523	CbGeAlD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0009	0.0145	CbGpPWpGaD
Bosentan—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000888	0.0497	CbGeAlD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000869	0.014	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000829	0.0133	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000814	0.0131	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00081	0.013	CbGpPWpGaD
Bosentan—EDNRA—brain—acquired immunodeficiency syndrome	0.0008	0.0447	CbGeAlD
Bosentan—EDNRA—lymph node—acquired immunodeficiency syndrome	0.000773	0.0432	CbGeAlD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00075	0.0121	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000736	0.0118	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000705	0.0113	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000705	0.0113	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000686	0.011	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000644	0.0104	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000623	0.01	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00062	0.00998	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000601	0.00967	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000594	0.00955	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000587	0.00945	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000583	0.00938	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000581	0.00934	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000556	0.00895	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000552	0.00888	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000537	0.00864	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000537	0.00863	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000505	0.00812	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000505	0.00812	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000503	0.00809	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000491	0.0079	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000483	0.00778	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000473	0.00761	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000473	0.00761	CbGpPWpGaD
Bosentan—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000448	0.025	CbGeAlD
Bosentan—EDNRA—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000444	0.00714	CbGpPWpGaD
Bosentan—CYP2C9—blood—acquired immunodeficiency syndrome	0.000426	0.0239	CbGeAlD
Bosentan—EDNRB—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000424	0.00682	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00042	0.00676	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000416	0.00669	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000398	0.00641	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000395	0.00636	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000384	0.00618	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000383	0.00616	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000378	0.00609	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00036	0.0058	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00036	0.0058	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00036	0.00579	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00036	0.00579	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000352	0.00566	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000346	0.00557	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000343	0.00552	CbGpPWpGaD
Bosentan—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000341	0.0191	CbGeAlD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000339	0.00545	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000339	0.00545	CbGpPWpGaD
Bosentan—CYP3A4—blood—acquired immunodeficiency syndrome	0.000325	0.0182	CbGeAlD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000324	0.00522	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000322	0.00518	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000318	0.00512	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000303	0.00488	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000274	0.00441	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000274	0.00441	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000271	0.00436	CbGpPWpGaD
Bosentan—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000264	0.0148	CbGeAlD
Bosentan—EDNRA—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000258	0.00415	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000258	0.00415	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000258	0.00414	CbGpPWpGaD
Bosentan—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000254	0.0142	CbGeAlD
Bosentan—EDNRA—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000252	0.00405	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000247	0.00397	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000246	0.00395	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000232	0.00373	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000228	0.00366	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000217	0.0035	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000217	0.00348	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000208	0.00334	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000208	0.00334	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000204	0.00327	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000204	0.00327	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000197	0.00316	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000196	0.00316	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000188	0.00302	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000185	0.00297	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000185	0.00297	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000177	0.00284	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	0.000169	0.00271	CbGpPWpGaD
Bosentan—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000595	CcSEcCtD
Bosentan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000166	0.000594	CcSEcCtD
Bosentan—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000593	CcSEcCtD
Bosentan—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000592	CcSEcCtD
Bosentan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000592	CcSEcCtD
Bosentan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000166	0.000591	CcSEcCtD
Bosentan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000165	0.000591	CcSEcCtD
Bosentan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000165	0.00059	CcSEcCtD
Bosentan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00059	CcSEcCtD
Bosentan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000588	CcSEcCtD
Bosentan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000588	CcSEcCtD
Bosentan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000164	0.000587	CcSEcCtD
Bosentan—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000587	CcSEcCtD
Bosentan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000586	CcSEcCtD
Bosentan—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000585	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000584	CcSEcCtD
Bosentan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000582	CcSEcCtD
Bosentan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000163	0.000582	CcSEcCtD
Bosentan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000582	CcSEcCtD
Bosentan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000581	CcSEcCtD
Bosentan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000581	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000581	CcSEcCtD
Bosentan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.00058	CcSEcCtD
Bosentan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00058	CcSEcCtD
Bosentan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000577	CcSEcCtD
Bosentan—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000577	CcSEcCtD
Bosentan—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.000577	CcSEcCtD
Bosentan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000576	CcSEcCtD
Bosentan—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000575	CcSEcCtD
Bosentan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000574	CcSEcCtD
Bosentan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000574	CcSEcCtD
Bosentan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000573	CcSEcCtD
Bosentan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000572	CcSEcCtD
Bosentan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00016	0.000571	CcSEcCtD
Bosentan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00016	0.000571	CcSEcCtD
Bosentan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00057	CcSEcCtD
Bosentan—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.00057	CcSEcCtD
Bosentan—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000569	CcSEcCtD
Bosentan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000568	CcSEcCtD
Bosentan—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000568	CcSEcCtD
Bosentan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000567	CcSEcCtD
Bosentan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000566	CcSEcCtD
Bosentan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000566	CcSEcCtD
Bosentan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000564	CcSEcCtD
Bosentan—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000564	CcSEcCtD
Bosentan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000158	0.000563	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000562	CcSEcCtD
Bosentan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000561	CcSEcCtD
Bosentan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00056	CcSEcCtD
Bosentan—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000558	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000556	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000156	0.0025	CbGpPWpGaD
Bosentan—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000555	CcSEcCtD
Bosentan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000554	CcSEcCtD
Bosentan—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000554	CcSEcCtD
Bosentan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000554	CcSEcCtD
Bosentan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.000554	CcSEcCtD
Bosentan—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000553	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000155	0.00249	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000155	0.00249	CbGpPWpGaD
Bosentan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000552	CcSEcCtD
Bosentan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000155	0.000552	CcSEcCtD
Bosentan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000552	CcSEcCtD
Bosentan—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000552	CcSEcCtD
Bosentan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00055	CcSEcCtD
Bosentan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00055	CcSEcCtD
Bosentan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000154	0.00055	CcSEcCtD
Bosentan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00055	CcSEcCtD
Bosentan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000548	CcSEcCtD
Bosentan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000548	CcSEcCtD
Bosentan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000545	CcSEcCtD
Bosentan—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000545	CcSEcCtD
Bosentan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000545	CcSEcCtD
Bosentan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.000545	CcSEcCtD
Bosentan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.000545	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000153	0.00245	CbGpPWpGaD
Bosentan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000544	CcSEcCtD
Bosentan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000152	0.000544	CcSEcCtD
Bosentan—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000543	CcSEcCtD
Bosentan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000542	CcSEcCtD
Bosentan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000152	0.000542	CcSEcCtD
Bosentan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00054	CcSEcCtD
Bosentan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00054	CcSEcCtD
Bosentan—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000539	CcSEcCtD
Bosentan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000538	CcSEcCtD
Bosentan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000538	CcSEcCtD
Bosentan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000537	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000537	CcSEcCtD
Bosentan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000536	CcSEcCtD
Bosentan—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000534	CcSEcCtD
Bosentan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000534	CcSEcCtD
Bosentan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000533	CcSEcCtD
Bosentan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000533	CcSEcCtD
Bosentan—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000532	CcSEcCtD
Bosentan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.000532	CcSEcCtD
Bosentan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000532	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000149	0.00239	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000149	0.00239	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000149	0.00239	CbGpPWpGaD
Bosentan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000149	0.000531	CcSEcCtD
Bosentan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.00053	CcSEcCtD
Bosentan—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000528	CcSEcCtD
Bosentan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000528	CcSEcCtD
Bosentan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000527	CcSEcCtD
Bosentan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000527	CcSEcCtD
Bosentan—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000527	CcSEcCtD
Bosentan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000527	CcSEcCtD
Bosentan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000147	0.000526	CcSEcCtD
Bosentan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000526	CcSEcCtD
Bosentan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000147	0.000526	CcSEcCtD
Bosentan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000525	CcSEcCtD
Bosentan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.000525	CcSEcCtD
Bosentan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000146	0.000523	CcSEcCtD
Bosentan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000523	CcSEcCtD
Bosentan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000522	CcSEcCtD
Bosentan—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000522	CcSEcCtD
Bosentan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000521	CcSEcCtD
Bosentan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000521	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000146	0.00234	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000146	0.00234	CbGpPWpGaD
Bosentan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000145	0.000518	CcSEcCtD
Bosentan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000145	0.000518	CcSEcCtD
Bosentan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000518	CcSEcCtD
Bosentan—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000518	CcSEcCtD
Bosentan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000517	CcSEcCtD
Bosentan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000144	0.000515	CcSEcCtD
Bosentan—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000515	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000514	CcSEcCtD
Bosentan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.000514	CcSEcCtD
Bosentan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000513	CcSEcCtD
Bosentan—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000143	0.00231	CbGpPWpGaD
Bosentan—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00051	CcSEcCtD
Bosentan—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.00051	CcSEcCtD
Bosentan—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000508	CcSEcCtD
Bosentan—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000507	CcSEcCtD
Bosentan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000507	CcSEcCtD
Bosentan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000506	CcSEcCtD
Bosentan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000506	CcSEcCtD
Bosentan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000504	CcSEcCtD
Bosentan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000504	CcSEcCtD
Bosentan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000503	CcSEcCtD
Bosentan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000503	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000141	0.00226	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000141	0.00226	CbGpPWpGaD
Bosentan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000501	CcSEcCtD
Bosentan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000501	CcSEcCtD
Bosentan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000499	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00014	0.00224	CbGpPWpGaD
Bosentan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.000497	CcSEcCtD
Bosentan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000497	CcSEcCtD
Bosentan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000496	CcSEcCtD
Bosentan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000496	CcSEcCtD
Bosentan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000496	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000495	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000139	0.00223	CbGpPWpGaD
Bosentan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000494	CcSEcCtD
Bosentan—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000491	CcSEcCtD
Bosentan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.00049	CcSEcCtD
Bosentan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000488	CcSEcCtD
Bosentan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000487	CcSEcCtD
Bosentan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000487	CcSEcCtD
Bosentan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000486	CcSEcCtD
Bosentan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000485	CcSEcCtD
Bosentan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000484	CcSEcCtD
Bosentan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000484	CcSEcCtD
Bosentan—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000484	CcSEcCtD
Bosentan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000483	CcSEcCtD
Bosentan—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000482	CcSEcCtD
Bosentan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000482	CcSEcCtD
Bosentan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000482	CcSEcCtD
Bosentan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000482	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000135	0.00216	CbGpPWpGaD
Bosentan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.00048	CcSEcCtD
Bosentan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000478	CcSEcCtD
Bosentan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000477	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000132	0.00213	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000132	0.00213	CbGpPWpGaD
Bosentan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000472	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000472	CcSEcCtD
Bosentan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.00047	CcSEcCtD
Bosentan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000469	CcSEcCtD
Bosentan—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000468	CcSEcCtD
Bosentan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000468	CcSEcCtD
Bosentan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000465	CcSEcCtD
Bosentan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000464	CcSEcCtD
Bosentan—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000464	CcSEcCtD
Bosentan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000462	CcSEcCtD
Bosentan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000462	CcSEcCtD
Bosentan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000461	CcSEcCtD
Bosentan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000461	CcSEcCtD
Bosentan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00046	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000128	0.00207	CbGpPWpGaD
Bosentan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000457	CcSEcCtD
Bosentan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000457	CcSEcCtD
Bosentan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000457	CcSEcCtD
Bosentan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000456	CcSEcCtD
Bosentan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000454	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000127	0.00204	CbGpPWpGaD
Bosentan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000451	CcSEcCtD
Bosentan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.00045	CcSEcCtD
Bosentan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000449	CcSEcCtD
Bosentan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000448	CcSEcCtD
Bosentan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000447	CcSEcCtD
Bosentan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000447	CcSEcCtD
Bosentan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000446	CcSEcCtD
Bosentan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000446	CcSEcCtD
Bosentan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000446	CcSEcCtD
Bosentan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000444	CcSEcCtD
Bosentan—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000443	CcSEcCtD
Bosentan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000443	CcSEcCtD
Bosentan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000438	CcSEcCtD
Bosentan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000436	CcSEcCtD
Bosentan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000432	CcSEcCtD
Bosentan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000431	CcSEcCtD
Bosentan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000431	CcSEcCtD
Bosentan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000429	CcSEcCtD
Bosentan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000429	CcSEcCtD
Bosentan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000429	CcSEcCtD
Bosentan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000425	CcSEcCtD
Bosentan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000425	CcSEcCtD
Bosentan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000423	CcSEcCtD
Bosentan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000423	CcSEcCtD
Bosentan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000422	CcSEcCtD
Bosentan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000417	CcSEcCtD
Bosentan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000416	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000116	0.00187	CbGpPWpGaD
Bosentan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000411	CcSEcCtD
Bosentan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000409	CcSEcCtD
Bosentan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000409	CcSEcCtD
Bosentan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000405	CcSEcCtD
Bosentan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000405	CcSEcCtD
Bosentan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000403	CcSEcCtD
Bosentan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000402	CcSEcCtD
Bosentan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000402	CcSEcCtD
Bosentan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000401	CcSEcCtD
Bosentan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.0004	CcSEcCtD
Bosentan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000399	CcSEcCtD
Bosentan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000399	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000111	0.00178	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000109	0.00176	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000109	0.00176	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000109	0.00176	CbGpPWpGaD
Bosentan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00039	CcSEcCtD
Bosentan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000388	CcSEcCtD
Bosentan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000386	CcSEcCtD
Bosentan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000385	CcSEcCtD
Bosentan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000384	CcSEcCtD
Bosentan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000384	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000108	0.00173	CbGpPWpGaD
Bosentan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000382	CcSEcCtD
Bosentan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000382	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000106	0.00171	CbGpPWpGaD
Bosentan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000379	CcSEcCtD
Bosentan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000373	CcSEcCtD
Bosentan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000372	CcSEcCtD
Bosentan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000371	CcSEcCtD
Bosentan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000366	CcSEcCtD
Bosentan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000362	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000101	0.00162	CbGpPWpGaD
Bosentan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000359	CcSEcCtD
Bosentan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000359	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.99e-05	0.00161	CbGpPWpGaD
Bosentan—Rash—Ritonavir—acquired immunodeficiency syndrome	9.96e-05	0.000356	CcSEcCtD
Bosentan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.95e-05	0.000355	CcSEcCtD
Bosentan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000354	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.91e-05	0.00159	CbGpPWpGaD
Bosentan—Headache—Ritonavir—acquired immunodeficiency syndrome	9.9e-05	0.000353	CcSEcCtD
Bosentan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000345	CcSEcCtD
Bosentan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.000342	CcSEcCtD
Bosentan—Rash—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000342	CcSEcCtD
Bosentan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.58e-05	0.000342	CcSEcCtD
Bosentan—Headache—Saquinavir—acquired immunodeficiency syndrome	9.53e-05	0.00034	CcSEcCtD
Bosentan—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.000335	CcSEcCtD
Bosentan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000329	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.19e-05	0.00148	CbGpPWpGaD
Bosentan—Rash—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000327	CcSEcCtD
Bosentan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.14e-05	0.000326	CcSEcCtD
Bosentan—Headache—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.000324	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.07e-05	0.00146	CbGpPWpGaD
Bosentan—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000322	CcSEcCtD
Bosentan—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000308	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.31e-05	0.00134	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.31e-05	0.00134	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.18e-05	0.00132	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.06e-05	0.0013	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.82e-05	0.00126	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.82e-05	0.00126	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.48e-05	0.0012	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.32e-05	0.00118	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.6e-05	0.00106	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.95e-05	0.000957	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.86e-05	0.000942	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.77e-05	0.000928	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	5.63e-05	0.000906	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.36e-05	0.000862	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.24e-05	0.000843	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	4.79e-05	0.00077	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.32e-05	0.000696	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.3e-05	0.000692	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	3.71e-05	0.000598	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	3.16e-05	0.000508	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.1e-05	0.000498	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.08e-05	0.000495	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	2.94e-05	0.000473	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.54e-05	0.000409	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.21e-05	0.000355	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.82e-05	0.000293	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	9.82e-06	0.000158	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	6.48e-06	0.000104	CbGpPWpGaD
